Market revenue in 2023 | USD 722.3 million |
Market revenue in 2030 | USD 985.3 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.97% in 2023. Horizon Databook has segmented the Spain healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is considered to be a popular destination for conducting clinical trials due to the presence of highly skilled hospitals & investigators, high research quality & patient recruitment volumes, and quick study initiation.
Spain has a rich history in clinical research and has seen a steady increase in clinical trial activity in recent years. In 2018, the Spanish Agency for Medicine & Health Products (AEMPS) approved 800 clinical trials for pharmaceuticals intended for human use.
The market in Spain is expected to witness significant growth due to the increasing number of innovations in clinical trials and the rising number of biosimilars & biologics.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Spain healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account